Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-3-24
pubmed:abstractText
The purpose of this study was to test the hypothesis that blockade of alpha1-adrenergic receptors may suppress the excessive ethanol consumption associated with acute withdrawal in ethanol-dependent rats. Following the acquisition and stabilization of operant ethanol self-administration in male Wistar rats, dependence was induced in half the animals by subjecting them to a 4-week intermittent vapor exposure period in which animals were exposed to ethanol vapor for 14h/day. Subsequent to dependence induction, the effect of alpha1-noradrenergic receptor antagonist prazosin (0.0, 0.25, 0.5, 1, 1.5, and 2.0mg/kg IP) was tested on operant responding for ethanol in vapor-exposed and control rats during acute withdrawal. In ethanol-dependent animals, prazosin significantly suppressed responding at the 1.5 and 2.0mg/kg doses, whereas only the 2.0mg/kg dose was effective in nondependent animals, identifying an increase in the sensitivity to prazosin in dependent animals. Conversely, at the lowest dose tested (0.25mg/kg), prazosin increased responding in nondependent animals, which is consistent with the effect of anxiolytics on ethanol self-administration in nondependent animals. None of the doses tested reliably affected concurrent water self-administration. These results suggest the involvement of the noradrenergic system in the excessive alcohol drinking seen during acute withdrawal in ethanol-dependent rats.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-10348615, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-10415666, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-10667795, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-10788758, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-11050302, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-12044468, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-12394282, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-12559372, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-12711656, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-1350359, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-14684447, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-15451394, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-15464135, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-15547454, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-15645218, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-16226365, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-16876134, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-16905443, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-17079660, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-17207096, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-17469930, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-2320661, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-2883663, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-3530023, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-3816531, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-4422511, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-4474673, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-575037, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-603310, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-603311, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-714985, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-8904984, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-8994212, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-9267529, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-9401667, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-9682998, http://linkedlifedata.com/resource/pubmed/commentcorrection/18358987-9726269
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0741-8329
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
91-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol.
pubmed:affiliation
Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, CA 92037, USA. bwalker@scripps.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural